Abstract:Objective:To evaluate the efficiency of high volume hemofiltration (HVHF) in the treatment of acute kidney injury(AKI)in patients with cardiotomy, and investigate the impact of therapy on prognosis in the different stage of AKI. Methodology:HVHF was performed in 25 patients with AKI after cardiotomy, including 16 males and 9 females, with average age of 15~80(56.4±16.80) years. Except 6 of the patients quitted in early stage of HVHF for economics, the remaining 19 patients were divided into three groups. They were group Ⅰ ( AKI Ⅰ stage,n=6) received HVHF when SCr was ≥0.3 mg/dl (≥26.4 μmol/L) or increased to ≥150%-200% (1.5-to 2-fold) from baseline, or0.5 ml/(kg·h) for6 hours, group Ⅱ (AKI Ⅱ stage,n=6), HVHF was started when SCr200%-300%(2-to 3-fold) from baseline, or0.5 ml/(kg·h) for12 hours, and group Ⅲ (AKI Ⅲ,n=7) had HVHF when SCr300%(3-fold) from baseline (SCr≥4.0 mg/dl (≥354 μmo/L) with an acute increase of at least 0.5 mg/dl(44 μmol/L), or0.5 ml/(kg·h) for12 hours. HVHF was performed with AV600 hemofilter (polysulfone, 1.6 m2). The rate of substitute fluid was at 4 000 ml/h by a pre-dilution route, and the rate of blood flow was 200-250 ml/min. Low molecular weight heparin and/or citrate were used for anticoagulation. The general conditions of each patients including blood pressure (BP), heart rate (HR), and temperature (T) were monitored every 30 minutes, and the blood gas analysis, serum biochemistry test were detected before and every 24 hours after the initiation of HVHF. APACHEⅡscores were evaluated every 12 hours during HVHF. Results:HVHF was well tolerated in all patients and the hospital mortality of 57.9%. The mortality of group I was lower than group III(50% vs 71.4%)while the patients in group I were more severe: the cardiopulmonary bypass(CPB)time[(244.2±170.46) vs (154.3±73.58)]and x-clamp time[(93.2±43.21) vs (82±59.59)]were both longer than group III,and more patients accepted IABP (66.7% vs 28.6%). After 12 hours' HVHF treatment, the high fever of patients was improved obviously(P0.05), while heart rate and MAP was maintained in normal range. After 24 hours' therapy, the serum creatinine and blood urea were both decreased (P0.05), and all survival patients had renal function recovered. After HVHF (60 hrs), we also found APACHE II scores improved significantly (P0.05). Conclusion:HVHF is technically possible in AKI patients after cardiotomy, which was an important treatment to post-cardiac operation patients with AKI and MODS. We also found that early HVHF performed in AKI I stage was better, which had lower mortality.

Application of Continuous Veno-Venous Hemodiafiltration to Severely Acute Renal Failure after Cardiac Surgery

The Early Application of Continuous Renal Replacement Therapy in Acute Renal Failure after Cardiac Surgery

Clinical Analysis of Continuous Venovenous Hemofiltration in Patients with Severe Congestive Heart Failure

[Continuous veno-venous haemofiltration in adult intensive therapy]

Clinical Study of the Influence of Continuous Hemofiltration on Gastrointestinal Dysfunction of the Patients with Intra-Abdominal Hypertension

The Effect of Substitution Fluid Rate on the Prognosis of Critical Acute Kidney Injury Patients Treated with Continuous Veno-Venous Hemorfltration Therapy

Effects of High Volume Hemofiltration on Acute Kidney Injury in Patients with Cardiotomy

The effect of continuous renal replacement therapy in patients with acute kidney injury on the serum levels of urea,creatinine and cystatin C

Adjunctive Continuous High-Volume Hemofiltration in Acute Severe Pancreatitis Patients: A Retrospective Study

Effect of the Intensity of Continuous Renal Replacement Therapy in Patients with Sepsis and Acute Kidney Injury: a Single-Center Randomized Clinical Trial

Opportunity for treatment of acute renal failure after cardiac vascular operation using continuous blood purification]

MO633: Survival Comparison Between CVVHDF and CVVH for Septic Acute Kidney Injury

Hypophosphatemia During Continuous Veno-Venous Hemofiltration is Associated with Mortality in Critically Ill Patients with Acute Kidney Injury

Comparison of the effects between continuous veno-venous hemofiltration and hemodialysis on patients with uremic encephalopathy

Continuous Venovenous Hemofi Ltration with Citrate Based,calcium-,Mag Nesium-Free Replacement Solution in Acut E Renal Failure Patients at High Risk of Bleeding

Nursing Care of Continuous Veno-Venous Hemofiltration for Patients with Hepatorenal Syndrome

A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding

Effects of Continuous Veno-Venous Hemofiltration in Gerontal Patients with Multiple Organ Failure

Clinlic Study of Continuous Venovenous Hemofiltration in Treatment of Hepatorenal Syndrome

Adjunctive Continuous High-Volume Hemofiltration in Patients with Acute Severe Pancreatitis: a Prospective Nonrandomized Study.

Early veno-venous haemodiafiltration for sepsis-related multiple organ failure